Search Results
Sep 07, 2026, 15:01 ET Did Acadia Healthcare Company, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Acadia Healthcare Company, Inc. (NASDAQ: ACHC) breached their fiduciary duties to shareholders.
More news about: Halper Sadeh LLP
Aug 28, 2026, 11:41 ET Orsini to Serve as Specialty Pharmacy Partner for Priovant's LISRAYA™ (brepocitinib)
patient care to ensure that No Patient is Left Behind™.Orsini holds accreditations with the Accreditation Commission for Health Care (ACHC), URAC and NABP. Orsini has earned URAC's Rare Disease Pharmacy Center of Excellence Designation and ACHC's Distinction in Rare Diseases and Orphan Drugs.
More news about: Orsini
Aug 25, 2026, 10:18 ET Did Acadia Healthcare Company, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Acadia Healthcare Company, Inc. (NASDAQ: ACHC) breached their fiduciary duties to shareholders.
More news about: Halper Sadeh LLP
Aug 21, 2026, 22:00 ET Acadia Healthcare Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Acadia Healthcare Company, Inc. - ACHC
Acadia Healthcare Company, Inc. (NasdaqGS: ACHC).
More news about: Kahn Swick & Foti, LLC
Aug 12, 2026, 15:27 ET Did Acadia Healthcare Company, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Acadia Healthcare Company, Inc. (NASDAQ: ACHC) breached their fiduciary duties to shareholders.
More news about: Halper Sadeh LLP
Jul 31, 2026, 10:00 ET Robbins LLP Notifies Acadia Healthcare (ACHC) Investors that the Lawsuit Survived Defendants' Motion to Dismiss - Contact Robbins LLP for Information
Robbins LLP reminds investors of their rights following the court's decision to allow securities claims against Acadia Healthcare Company (NASDAQ: ACHC) to proceed.
More news about: Robbins LLP
Jul 20, 2026, 16:45 ET Cardinal Health expands home care business with two tuck-in acquisitions
provider specializing in urology, incontinence, and wound care supplies delivered directly to patients. As an Accreditation Commission for Health Care (ACHC) accredited organization, Strive Medical manages the full insurance billing process – including Medicare, Medicaid, and over 5,000 private insurance
More news about: Cardinal Health
Jul 13, 2026, 16:00 ET Warburg Pincus-Led Investor Group Agrees to Acquire Controlling Interest in PANTHERx® Rare
all 50 states and was the first national pharmacy to achieve dual accreditations in rare disease from the Accreditation Commission for Health Care (ACHC) and Utilization Review Accreditation Commission (URAC). PANTHERx is also a nine-time winner of the prestigious MMIT Patient Choice Award for patient
More news about: Warburg Pincus LLC
Jun 18, 2026, 11:44 ET ChemoMouthpiece, LLC Announces Partnership with Zeal Specialty Pharmacy to Support Access to the Chemo Mouthpiece® Oral Cooling Device
partners alike. That efficiency serves one great purpose: to improve the experience between a patient and their care.Dually accredited by URAC and ACHC, and holding Rare Disease Center of Excellence designations from both (one of only six U.S. pharmacies with that distinction), Zeal can dispense nationwide
More news about: Chemomouthpiece, LLC
May 26, 2026, 09:00 ET Orsini to Serve as Contracted Specialty Pharmacy for Gilead's Hepcludex® (bulevirtide‑gmod)
personalized patient care to ensure that No Patient is Left Behind™.Orsini holds accreditations with the Accreditation Commission for Health Care (ACHC), URAC and NABP. Orsini has earned URAC's Rare Disease Pharmacy Center of Excellence Designation and ACHC's Distinction in Rare Diseases and Orphan Drugs.
More news about: Orsini
Apr 28, 2026, 11:50 ET PANTHERx® Rare Pharmacy Earns 2026 MMIT Patient Choice Award for Patient Satisfaction
all 50 states and was the first national pharmacy to achieve dual accreditations in rare disease from the Accreditation Commission for Health Care (ACHC) and Utilization Review Accreditation Commission (URAC). PANTHERx is also a nine-time winner of the prestigious MMIT Patient Choice Award for patient
More news about: PANTHERx Rare Pharmacy
Apr 27, 2026, 08:04 ET CSI Pharmacy Becomes First Multi-Location Specialty Pharmacy to Achieve ACHC Distinction in Ig Therapy in Partnership with IgNS
Distinction in Immunoglobulin (Ig) Therapy, a prestigious accreditation jointly created by the Accreditation Commission for Health Care (ACHC) and the Immunoglobulin National Society (IgNS). Awarded across CSI Pharmacy's West Chester, Ohio; Enfield, Connecticut; and Nash, Texas specialty pharmacies,
More news about: CSI Pharmacy
Apr 23, 2026, 17:27 ET Accord Specialty Pharmacy Named Finalist in MMIT's 11th Annual Retail Specialty Pharmacy Patient Choice Awards
Specialty Pharmacy Patient Choice Awards - MMITNetwork.About Accord Specialty Pharmacy:Accord Specialty Pharmacy is an ACHC-accredited, multi-state licensed independent specialty pharmacy located in Central Florida, dedicated to delivering high-quality, patient-centered care for
More news about: Accord Specialty
Apr 20, 2026, 09:00 ET Orsini Selected as the Exclusive Specialty Pharmacy and Home Infusion Partner for Denali Therapeutics' AVLAYAH™ (tividenofusp alfa-eknm)
care to ensure that No Patient is Left Behind™. Orsini holds accreditations with the Accreditation Commission for Health Care (ACHC), The Joint Commission, URAC and NABP. Orsini has earned URAC's Rare Disease Pharmacy Center of Excellence Designation and ACHC's Distinction in Rare Diseases
More news about: Orsini
Mar 23, 2026, 13:33 ET PANTHERx® Rare Selected by UCB as the Exclusive Specialty Pharmacy for the Distribution of KYGEVVI™
all 50 states and was the first national pharmacy to achieve dual accreditations in rare disease from the Accreditation Commission for Health Care (ACHC) and Utilization Review Accreditation Commission (URAC). PANTHERx is also the eight-time winner of the prestigious MMIT Patient Choice Award for patient
More news about: PANTHERx Rare Pharmacy
Mar 23, 2026, 09:00 ET Orsini to Serve as Single-Source Specialty Pharmacy Partner for Glaukos' Epioxa™
patient care to ensure that No Patient is Left Behind™.Orsini holds accreditations with the Accreditation Commission for Health Care (ACHC), URAC and NABP. Orsini has earned URAC's Rare Disease Pharmacy Center of Excellence Designation and ACHC's Distinction in Rare Diseases and Orphan Drugs.
More news about: Orsini
Mar 20, 2026, 12:58 ET PANTHERx® Rare Selected by Rhythm Pharmaceuticals Inc. as the Exclusive U.S. Specialty Pharmacy for the Expanded Indication for IMCIVREE® (setmelanotide)
all 50 states and was the first national pharmacy to achieve dual accreditations in rare disease from the Accreditation Commission for Health Care (ACHC) and Utilization Review Accreditation Commission (URAC). PANTHERx is also the eight-time winner of the prestigious MMIT Patient Choice Award for patient
More news about: PANTHERx Rare Pharmacy
Mar 09, 2026, 09:00 ET Orsini Selected by Immedica Pharma US Inc. as Exclusive Specialty Pharmacy and Hub Services Partner for LOARGYS® (pegzilarginase-nbln)
patient care to ensure that No Patient is Left Behind™.Orsini holds accreditations with the Accreditation Commission for Health Care (ACHC), The Joint Commission, URAC and NABP. Orsini has earned URAC's Rare Disease Pharmacy Center of Excellence Designation and ACHC's Distinction in Rare Diseases
More news about: Orsini
Mar 05, 2026, 09:30 ET Anxiety Treatment Boom: GAD Therapies Poised for Multi-Billion Dollar Expansion
Companies in the biotech space of interest include: Helus PharmaTM (NASDAQ: HELP) (Cboe CA: HELP), Acadia Healthcare Company, Inc. (NASDAQ: ACHC), Johnson & Johnson (NYSE: JNJ), BrainsWay Ltd. (NASDAQ: BWAY), Firefly Neuroscience, Inc. (NASDAQ: AIFF).
More news about: Market News Updates
Feb 26, 2026, 08:00 ET Orsini Now Distributing Gene Therapies LYFGENIA™, ZYNTEGLO™, SKYSONA™
patient care to ensure that No Patient is Left Behind™.Orsini holds accreditations with the Accreditation Commission for Health Care (ACHC), The Joint Commission, URAC and NABP. Orsini has earned URAC's Rare Disease Pharmacy Center of Excellence Designation and ACHC's Distinction in Rare Diseases
More news about: Orsini
Feb 25, 2026, 09:47 ET As Rare Disease Drug Approvals Accelerate, PANTHERx® Releases Research on Strengthening Care Coordination
U.S. territories and was the first national pharmacy to achieve dual accreditations in rare disease from the Accreditation Commission for Health Care (ACHC) and Utilization Review Accreditation Commission (URAC). PANTHERx is also the eight-time winner of the prestigious MMIT Patient Choice Award for patient
More news about: PANTHERx Rare Pharmacy
Feb 18, 2026, 09:00 ET eNavvi Announces Strategic Alliance with ACHC to Elevate Standards in Digital Prescribing and Compounding Pharmacy Networks
www.enavvi.com.About ACHC The Accreditation Commission for Health Care (ACHC) is a nonprofit accreditation organization that has stood as a symbol of quality and excellence since 1986. ACHC is the parent organization of PCAB (Pharmacy Compounding Accreditation
More news about: eNavvi
Feb 02, 2026, 09:00 ET eNavvi Welcomes Triple-Accredited Integrity Compounding Pharmacy to Digital Prescription Network
Sandy Springs, Georgia, they were the first in their region to achieve triple accreditation from the Accreditation Commission for Health Care (ACHC). By onboarding Integrity, eNavvi ensures that its users can access a broad spectrum of complex therapies—including those requiring hazardous drug handling—with
More news about: eNavvi
Jan 28, 2026, 08:43 ET COMPASS SURGICAL PARTNERS AND CARDIOVASCULAR INSTITUTE OF NORTHWEST FLORIDA BRING FIRST OUTPATIENT CATH LAB TO REGION
peripheral artery interventions, and dialysis access procedures. The partners plan to seek accreditation from the Accreditation Commission for Health Care (ACHC)."Cardiovascular procedures are one of the fastest-growing segments in the ASC sector," said
More news about: Compass Surgical Partners
Jan 13, 2026, 08:00 ET Orsini Selected as Specialty Pharmacy Partner for Cytokinetics's MYQORZO™ (aficamten)
patient care to ensure that No Patient is Left Behind™.Orsini holds accreditations with the Accreditation Commission for Health Care (ACHC), The Joint Commission, URAC and NABP. Orsini has earned URAC's Rare Disease Pharmacy Center of Excellence Designation and ACHC's Distinction in Rare Diseases
More news about: Orsini